O'Shaughnessy Asset Management, LLC Nektar Therapeutics Transaction History

O'Shaughnessy Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$10.83 - $18.41 $379 - $644	-35 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$16.52 - $20.4 $82 - $102	-5 Reduced 12.5%	35 $1,000
Q4 2020 Feb 11, 2021	SELL	$15.77 - $19.03 $157 - $190	-10 Reduced 20.0%	40 $1,000
Q3 2020 Nov 12, 2020	SELL	$16.59 - $24.79 $713 - $1,065	-43 Reduced 46.24%	50 $1,000
Q2 2020 Aug 13, 2020	BUY	$16.86 - $23.44 $1,567 - $2,179	93 New	93 $2,000
Q1 2020 May 13, 2020	SELL	$14.47 - $27.96 $217 - $419	-15 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$15.87 - $23.12 $238 - $346	15 New	15 $0

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.